Tien Liang BioTech Co., Ltd. (4127.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan

Price
35.25 TWD
Market cap
1.61 bn TWD
P/E (2025)
–
P/S (2025)
3.15
Dividend yield
0.00 %
Net margin
-2.00 %
Return on equity (ROE)
-2.16 %
Return on assets (ROA)
-0.87 %

Tien Liang BioTech Co., Ltd. financials

Fiscal year20242025
Revenue385.21 m TWD511.79 m TWD
Gross profit229.91 m TWD287.94 m TWD
Operating income593,000.00 TWD-16.14 m TWD
EBIT16.18 m TWD-621,000.00 TWD
Net income11.70 m TWD-10.25 m TWD
Diluted EPS – continuing operations0.25 TWD-0.22 TWD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.